I still think Pfizer is in the loop on the hcv program.
Imagine another big pharma gets the deal and turn the drug into a blockduster one. That wouldn't look too good on Pfizer's ceo. He would have a lot of explaining to do to his board and shareholders. After all they did have positive results with the preclinical trials.
blt to acquire tacere therapeutics!, page-24
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)